Insulin Delivery Devices Market is expected to grow at 6.8% by 2031. Diabetes is one of the leading lifestyle diseases observed across the world. The key factors assisting the overall growth of the insulin delivery market are the mounting prevalence of diabetes and rising public awareness related to diabetes management and diagnostics. Insulin plays vital role in maintenance of sugar levels along with the systematic execution of all other physiological and cellular actions. The growing incidence of diabetes around the world is observed due to factors such as the increasing prevalence of obesity, and practice of sedentary lifestyle in the working population. In addition, technological upgradation and superiority in the novel insulin delivery devices such as insulin inhaler and portable insulin pumps are also assisting the market growth of insulin delivery devices market. Market experts also suggested that the disease incidence rate of diabetes is rapidly increasing especially in children and adults, which is expected to be the boosting factor for global insulin delivery devices industry in the near future.
The insulin delivery devices market on the basis of product type is segmented into jet injectors, syringes, pumps and insulin pens. Insulin syringes are designed for self-administration of doses and have many user-friendly features such as short needles which reduce pain in patients. Insulin pen comprises insulin cartridge, dial and a needle; primarily used with disposable needles for the delivery of insulin doses. The compact design of these devices allows discreet administration of insulin.
The key drivers assisting the overall market growth of insulin delivery devices are increasing awareness related to diabetes management, and mounting issues related to obesity, sedentary lifestyle, and lack of early diagnosis in developing countries. North America is the leading regional market for insulin delivery devices and is trailed by Europe due to the existence of a large population suffering with diabetes, and high hospital expenses are forcing diabetes patients to opt for self-injections for home use. The U.S. attributed the largest share for the insulin delivery devices market due to rising patient’s inclination towards novel insulin delivery devices and supportive reimbursement scenario. Other countries such as Germany, France, U.K. and Canada are also witnessing high growth in the market. Asia-Pacific insulin delivery devices market was observed as the fastest-growing region due to the presence of large pool of diabetes patients and the rising accessibility of patients towards novel technologies in insulin delivery.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
The insulin delivery devices market on the basis of product type is segmented into jet injectors, syringes, pumps and insulin pens. Insulin syringes are designed for self-administration of doses and have many user-friendly features such as short needles which reduce pain in patients. Insulin pen comprises insulin cartridge, dial and a needle; primarily used with disposable needles for the delivery of insulin doses. The compact design of these devices allows discreet administration of insulin.
The key drivers assisting the overall market growth of insulin delivery devices are increasing awareness related to diabetes management, and mounting issues related to obesity, sedentary lifestyle, and lack of early diagnosis in developing countries. North America is the leading regional market for insulin delivery devices and is trailed by Europe due to the existence of a large population suffering with diabetes, and high hospital expenses are forcing diabetes patients to opt for self-injections for home use. The U.S. attributed the largest share for the insulin delivery devices market due to rising patient’s inclination towards novel insulin delivery devices and supportive reimbursement scenario. Other countries such as Germany, France, U.K. and Canada are also witnessing high growth in the market. Asia-Pacific insulin delivery devices market was observed as the fastest-growing region due to the presence of large pool of diabetes patients and the rising accessibility of patients towards novel technologies in insulin delivery.
Key Players Identified for Insulin Delivery Devices Market Include but are Not Limited to:
- Novo Nordisk A/.- Sanof.
- Eli Lilly and Compan.
- Biocon Ltd.
- Ypsomed A.
- Wockhardt Ltd.
- Medtroni.
- Abbott Laboratorie.
- F. Hoffmann-La Roche, Ltd.
Historical & Forecast Period
This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Insulin Delivery Devices market are as follows.- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Insulin Delivery Devices market and their expected impact during the forecast period.
Segmentation
Type
- Insulin Pen
- Reusable Pen
- Disposable Pen
- Insulin Pump
- Traditional Pump
- Disposable Pump
- Insulin Syringes
- Insulin Jet Injectors
- Insulin Inhalers
End-use
- Hospitals
- Homecare
- Others
Region Segment (2021 - 2031; US$ Million)
- North America
- U.S.
- Canada
- Rest of North America
- UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Insulin Delivery Devices market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Insulin Delivery Devices market?
- Which is the largest regional market for Insulin Delivery Devices market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Insulin Delivery Devices market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Insulin Delivery Devices market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface
2. Executive Summary
3. Insulin Delivery Devices Market: Competitive Analysis
4. Insulin Delivery Devices Market: Macro Analysis & Market Dynamics
5. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
6. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
7. North America Insulin Delivery Devices Market, 2021-2031, USD (Million)
8. UK and European Union Insulin Delivery Devices Market, 2021-2031, USD (Million)
9. Asia Pacific Insulin Delivery Devices Market, 2021-2031, USD (Million)
10. Latin America Insulin Delivery Devices Market, 2021-2031, USD (Million)
11. Middle East and Africa Insulin Delivery Devices Market, 2021-2031, USD (Million)
12. Company Profile
List of Figures
List of Tables
Companies Mentioned
- Novo Nordisk A/S
- Sanofi
- Eli Lilly and Company
- Biocon Ltd.
- Ypsomed AG
- Wockhardt Ltd.
- Medtronic
- Abbott Laboratories
- F. Hoffmann-La Roche, Ltd.
